| May 14 |
TEVA
|
Teva Pharmaceutical Industries Limited (TEVA) BofA Securities 2024 Health Care Conference (Transcript) |
| May 14 |
TEVA
|
Is Aldeyra Therapeutics (ALDX) Stock Outpacing Its Medical Peers This Year? |
| May 14 |
TEVA
|
Israel’s Once-Dominant Drugmaker Is Revived by Innovation |
| May 13 |
TEVA
|
Should Value Investors Buy Teva Pharmaceutical Industries (TEVA) Stock? |
| May 13 |
CANF
|
Can-Fite: 75 Oncologists and Coordinators from Europe US and Israel Participated in a Conference Aimed at Accelerating Patient Enrolment for the Pivotal Phase 3 Advanced Liver Cancer Study |
| May 12 |
TEVA
|
These 10 Large Cap Stocks Shined Brightest Last Week (May 5-May 11, 2024): Are They In Your Portfolio? |
| May 10 |
CANF
|
Can-Fite BioPharma and Nutriband Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV |
| May 10 |
CANF
|
Can-Fite receives FDA IND clearance for Phase IIb MASH treatment trial |
| May 9 |
TEVA
|
TEVA Q1 Earnings Miss, Schizophrenia Study Meets Goal, Stock Up |
| May 9 |
CYBR
|
CyberArk Previews IMPACT 24: The Identity Security Conference |
| May 9 |
TEVA
|
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q1 2024 Earnings Call Transcript |
| May 9 |
TEVA
|
Affirm stock sinking, Good Buy or Goodbye: Market Domination |
| May 9 |
CANF
|
Can-Fite stock up on FDA IND clearance for namodenoson to treat MASH patients in mid-stage study |
| May 9 |
TEVA
|
Teva Pharmaceutical Industries First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags |
| May 9 |
TEVA
|
Teva Pharmaceutical: 6 Takeaways From Q1 2024 Earnings Results |
| May 9 |
CANF
|
Can-Fite: FDA Grants IND Clearance for Namodenoson to Treat MASH Patients in a Phase IIb Study |
| May 9 |
TEVA
|
Teva and Medincell report positive data for TEV-‘749 in schizophrenia trial |
| May 9 |
TEVA
|
Teva: Sustained Revenue Growth Amid Financial Strain (Rating Downgrade) |
| May 8 |
TEVA
|
Teva Pharmaceutical Industries (TEVA) Q1 2024 Earnings Call Transcript |
| May 8 |
TEVA
|
Teva Pharmaceutical Industries Limited (TEVA) Q1 2024 Earnings Call Transcript |
